Cargando…
Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented event, and in order to control its spread and minimize its damages, all efforts are immediately mobilized. Mass vaccination is considered a promising solution to combat this universal issue. However, given the urgent need for vacci...
Autores principales: | Shahrigharahkoshan, Shaghayegh, Gagnon, Louis-Philippe, Mathieu, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609955/ https://www.ncbi.nlm.nih.gov/pubmed/34853744 http://dx.doi.org/10.7759/cureus.19005 |
Ejemplares similares
-
Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
por: Ahmer, Sadaf, et al.
Publicado: (2022) -
Gabapentin-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report
por: Órfão, Ana, et al.
Publicado: (2023) -
Methotrexate-Induced Leukocytoclastic Vasculitis
por: Dewan, Pooja, et al.
Publicado: (2021) -
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021) -
Leukocytoclastic Vasculitis: Depiction of the Diagnostic Dilemma
por: Bhesania, Siddharth, et al.
Publicado: (2021)